Search research articles
Contact Us
Filters
Showing results (371-380 of 392) with videos related to
Page
of 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S J Wong, T Karrison, D N Hayes, et al.
Elife
|
September 8, 2018
<i>tp53</i> deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish
Myron S Ignatius, Madeline N Hayes, Finola E Moore, et al.
International Journal of Population Data Science
|
March 1, 2024
Data resource profile: COVid VAXines effects on the aged (COVVAXAGE)
Kaleen N Hayes, Daniel A Harris, Andrew R Zullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2023
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer
A J Rosenberg, C-Y Liao, T Karrison, et al.
Nature Biomedical Engineering
|
September 2, 2025
Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis
Hyun-Kee Min, Hongyu Zhao, Alexander Bahcheli, et al.
Neuron
|
March 20, 2026
Soluble α2δ-1, altered in disease CSF, modulates network homeostasis and rescues deficits in a neuropsychiatric mouse model
Marc Dos Santos, Marc P Forrest, Ewa Bomba-Warczak, et al.
Kidney International
|
November 1, 2023
A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO)
Wesley N Hayes, Emma Laing, Rosemary Brown, et al.
Journal of Clinical Epidemiology
|
September 25, 2024
Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making
Mina Tadrous, Theresa Aves, Christine Fahim, et al.
American Journal of Epidemiology
|
November 21, 2024
Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology-endorsed systematic review of methodology
Kaleen N Hayes, Joshua David Niznik, Danijela Gnjidic, et al.
Elife
|
June 2, 2023
Defining function of wild-type and three patient-specific <i>TP53</i> mutations in a zebrafish model of embryonal rhabdomyosarcoma
Jiangfei Chen, Kunal Baxi, Amanda E Lipsitt, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 392) with videos related to
Sort By:
Page
of 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S J Wong, T Karrison, D N Hayes, et al.
Elife
|
September 8, 2018
<i>tp53</i> deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish
Myron S Ignatius, Madeline N Hayes, Finola E Moore, et al.
International Journal of Population Data Science
|
March 1, 2024
Data resource profile: COVid VAXines effects on the aged (COVVAXAGE)
Kaleen N Hayes, Daniel A Harris, Andrew R Zullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2023
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer
A J Rosenberg, C-Y Liao, T Karrison, et al.
Nature Biomedical Engineering
|
September 2, 2025
Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis
Hyun-Kee Min, Hongyu Zhao, Alexander Bahcheli, et al.
Neuron
|
March 20, 2026
Soluble α2δ-1, altered in disease CSF, modulates network homeostasis and rescues deficits in a neuropsychiatric mouse model
Marc Dos Santos, Marc P Forrest, Ewa Bomba-Warczak, et al.
Kidney International
|
November 1, 2023
A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO)
Wesley N Hayes, Emma Laing, Rosemary Brown, et al.
Journal of Clinical Epidemiology
|
September 25, 2024
Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making
Mina Tadrous, Theresa Aves, Christine Fahim, et al.
American Journal of Epidemiology
|
November 21, 2024
Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology-endorsed systematic review of methodology
Kaleen N Hayes, Joshua David Niznik, Danijela Gnjidic, et al.
Elife
|
June 2, 2023
Defining function of wild-type and three patient-specific <i>TP53</i> mutations in a zebrafish model of embryonal rhabdomyosarcoma
Jiangfei Chen, Kunal Baxi, Amanda E Lipsitt, et al.
Page
of 40